AMZN
Amazon.com, Inc.
AMZN has the edge over ANF overall, supported by stronger modeled upside and lower modeled downside.
ANF
Abercrombie & Fitch Co.
ANF's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ANF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
ANF's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ANF in the historical PE scenario, which offers more potential upside but is not a forecast.
ANF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.8x | $89.96 | -40% |
| Forward | 12x | $150 | — |
| Fair | 13x | $155 | +2.9% |
| Current | 13x | $150 | — |
| Expensive | 26x | $299 | +98% |
Historical ranges are pointers, not guarantees.
ANF's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ANF Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
ANF has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ANF on earnings, with more consistent year-over-year improvement.
ANF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.43 | +7.2% |
| Q3 2026 | $11.60 | +10% |
| Q2 2026 | $10.34 | +2% |
| Q1 2026 | $10.46 | -2.2% |
| Q4 2025 | $10.41 | +3% |
| Q3 2025 | $10.55 | +12% |
| Q2 2025 | $10.14 | +26% |
| Q1 2025 | $10.69 | +72% |
| Q4 2024 | $10.11 | +153% |
ANF earned $11.60 per share over the past year, up 10% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ANF on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
ANF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +4.8% |
| Q2 2026 | $1.1B | +1.5% |
| Q1 2026 | $1.7B | +5.4% |
| Q4 2025 | $1.3B | +6.8% |
| Q3 2025 | $1.2B | +6.6% |
| Q2 2025 | $1.1B | +7.5% |
| Q1 2025 | $1.6B | +9.1% |
| Q4 2024 | $1.2B | +14% |
ANF's revenue has grown year over year for 15 quarters in a row: $1.3B last quarter, up 4.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +2.8 points |
| Q2 2026 | 8% | -1.3 points |
| Q1 2026 | 14% | -2 points |
| Q4 2025 | 12% | -2.8 points |
| Q3 2025 | 17% | +1.6 points |
| Q2 2025 | 9.3% | -3.5 points |
| Q1 2025 | 16% | +0.8 points |
| Q4 2024 | 15% | +1.8 points |
ANF has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ANF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $201.1M | +297% |
| Q2 2026 | -$17.1M | +$37.7M |
| Q1 2026 | $250.6M | -2.4% |
| Q4 2025 | $131.8M | +43% |
| Q3 2025 | $50.7M | -59% |
| Q2 2025 | -$54.8M | -198% |
| Q1 2025 | $256.8M | -6.3% |
| Q4 2024 | $92.2M | -2.9% |
ANF has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ANF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.6% | -1.6M shares |
| 1 year | -9.3% | -4.5M shares |
| 3 years | -15% | -7.5M shares |
| 5 years | -31% | -20.1M shares |
| Available history | -31% | -19.9M shares |
ANF has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $181.4M |
| Q2 2026 | $105M |
| Q1 2026 | $100M |
| Q4 2025 | $100M |
| Q3 2025 | $51.2M |
| Q2 2025 | $200M |
| Q1 2025 | $100M |
| Q4 2024 | $99.8M |
ANF spent $486M buying back its own shares over the past year, up 7.9% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ANF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
ANF has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ANF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.7 | Neutral |
| Stochastic | 78.3 | Neutral |
ANF's weekly RSI is 65 (neutral) and its Stochastic is 78 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
ANF PE vs Consumer Cyclical Sector
| Metric | ANF | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 18x | 28% below |
| PE % | 48 | 47 | 1 pt above |
ANF has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
ANF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $148.5 | 1.4% above |
| 20 week MA | $128.5 | 17% above |
| 50 week MA | $108.1 | 39% above |
| 100 week MA | $100.3 | 50% above |
| 200 week MA | $96.1 | 57% above |
ANF is in an uptrend: it's above all five of its weekly moving averages, and 57% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
ANF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.3 | $20.1 | +16% |
| 2021 | $20.1 | $34.4 | +71% |
| 2022 | $34.4 | $22.3 | -35% |
| 2023 | $22.3 | $88.2 | +296% |
| 2024 | $88.2 | $153.9 | +74% |
| 2025 | $153.9 | $126.8 | -18% |
| 2026 YTD | $126.8 | $150.5 | +19% |
ANF has the edge over AMZN on returns for 2026, with the stronger performance.